Company intelligence / Profile preview

Pioneer Group

London, England, United Kingdomthepioneergroup.com ↗

Ownership: Private
Employees: ~150
Development stage: Other

Overview

Pioneer Group does not have its own clinical results. It supports and invests in early-stage life science ventures across the UK and Ireland. Its accelerator programs have helped numerous startups advance from idea to commercialisation.

Modalities: Small moleculeBiologicAntibodyCell therapyGene therapyDigital health
Industry: Investors

Partnerships

AbbVie – Golden Ticket programme for early-stage biotech/therapies in immunology/oncology/neuroscience/eye careAstraZeneca – AI in Health Accelerator Programme partnership with Innovate UK & MRC for AI-driven healthcare innovation supportNovo Nordisk – Golden Ticket programme partnership to accelerate digital health innovation

Beyond the preview

Go deeper on Pioneer Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pioneer Group.

Explore the full profile